SNGX 11/30 confirmation news the real deal? Or another run up to dilute, r/s, and fail another 2-3 years? One can only hope.. GLTA
“7:30a ET 11/30/2023 - PR Newswire Soligenix Receives FDA IND Clearance for Phase 2 Clinical Trial of Dusquetide in the Treatment of Aphthous Ulcers in Beh?et's Disease”